Medial EarlySign Presenting at Lab Institute 2019

Share:

Share on twitter
Share on linkedin
Share on facebook
Share on email
G2 Lab Institute 2019

Medial EarlySign Presenting at Lab Institute 2019

Medial EarlySign’s CMO, Dr. Jeremy Orr, will be speaking at a session entitled “Analyte to Algorithm to Action to Impact” at G2 Intelligence’s 37th Annual Lab Institute.

 

Machine learning models are beginning to play a critical role in care transformation efforts, especially as they relate to risk adjustment, population health, and alternative payment models. Dr. Orr will review the development and validation of several powerful models to predict high burden disease at earlier, more treatable stages. He will further review the challenge of getting these predictors into clinical and laboratory workflow, how ML results are messaged to both patients and clinicians, and how clinical outcomes related to these predictors are measured. Dr. Orr will close with a look ahead to how ML models and approaches will improve care delivery for laboratorians and other clinicians, and how ML empowers the transition to value based care.

 

The presentation will take place on Wednesday, November 6, 2019 at Crystal Gateway Marriott, Arlington, VA.

 

Share:

Share on twitter
Share on linkedin
Share on facebook
Share on email

Are you looking to solve high-burden disease challenges?